Discount retailers also emerged as a way to play the big tariff selloff of 2025, as the Dow Jones Industrial Average ...
The pharma and biotech sector has been under pressure since Donald Trump returned to the White House earlier this year.
Shares of U.S. drugmakers fell on Monday after reports that the Food and Drug Administration's top vaccine official, Peter ...
By Manas Mishra (Reuters) -Shares of U.S. drugmakers fell before the bell on Monday after reports that the Food and Drug ...
8h
The Print on MSNIndian drugmakers relieved as they dodge Trump tariffs but medical devices industry takes a hitHowever, in his Wednesday speech, Trump indicated that tariffs on pharmaceutical imports may not be totally off the table.
Analysts said tariffs would send prescription drug prices higher. Generic drugs and ingredients that are largely made ...
Drugmakers breathed a sigh of relief Wednesday after President Trump didn’t announce pharmaceutical tariffs. Plus, language ...
Pharmacy benefit managers OptumRx and Express Scripts have asked the federal judge overseeing nationwide litigation over the ...
Biopharma is seen as a safe haven for investors due to its high-margin business model and flexibility in dealing with ...
Trump imposed a 10% tariff on most U.S. imports, as well as much higher levies on dozens of rivals and allies alike, but ...
With concerns mounting and speculation swirling, the particulars of President Donald Trump’s much-touted “Liberation Day” ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results